Recently, a genetic examination of more than 150,000 individuals revealed that 33 (0.02%) had a CTNNA1 loss-of-function mutation and of those only 4 (12%) had diffuse gastric cancer, but 22 (67%) had breast cancer [13]. This evidence concerns the gene CTNNA1 and breast cancer.